Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (19)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Diferencias de sexo en los beneficios de la anticoagulación en pacientes ancianos con fibrilación auricular: un subanálisis del estudio EMERG-AF

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 35, Núm. 4, pp. 252-260

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Long-term prognosis and emergency management for patients with an implantable cardioverter defibrillator: the EMERGE-ICD study

    Emergencias, Vol. 35, Núm. 3, pp. 185-195

  5. Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

    The Lancet Regional Health - Europe, Vol. 28

2022

  1. A bacteraemia risk prediction model: development and validation in an emergency medicine population

    Infection, Vol. 50, Núm. 1, pp. 203-221

  2. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

  3. Modelo asistencial ambulatorio de alta resolución COVID-A2R: una solución efectiva en el servicio de urgencias para pacientes con COVID-19 y riesgo de evolución desfavorable

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 34, Núm. 2, pp. 111-118

  4. PBM: Now more than ever necessary

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 69, Núm. 6, pp. 351-354

  5. Usefulness of the 5MPB-Toledo model to predict bacteremia in the elderly patient

    Infectio, Vol. 26, Núm. 2, pp. 128-136

  6. Validation of a predictive model for bacteraemia (MPB5-Toledo) in the patients seen in emergency departments due to infections

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 3, pp. 102-112

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. A multidrug-resistant microorganism infection risk prediction model: development and validation in an emergency medicine population

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 39, Núm. 2, pp. 309-323

2019

  1. Cardioversion in recent onset atrial fibrillation

    Emergencias, Vol. 31, Núm. 4, pp. 227-233

2017

  1. Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)

    Stroke, Vol. 48, Núm. 5, pp. 1344-1352

  2. Prognostic accuracy of SIRS criteria, qSOFA score and GYM score for 30-day-mortality in older non-severely dependent infected patients attended in the emergency department

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 12, pp. 2361-2369

2014

  1. Creación de una escala para evaluar la gravedad de las exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica (EA-EPOC) en los servicios de urgencias hospitalarios

    Emergencias, Vol. 26, Núm. 4, pp. 251-258

2013

  1. Predictors of hospital admission in exacerbations of chronic obstructive pulmonary disease

    International Journal of Tuberculosis and Lung Disease, Vol. 17, Núm. 12